Proactive Investors - Run By Investors For Investors

Futura Medical's Ken James discusses new safety data on lead treatment

Futura Medical PLC's (LON:FUM) head of R&D Ken James walks Proactive New York's Christine Corrado through new safety data relevant to sexual partners on its lead product MED2005.

The treatment's a fast-acting gel for men who suffer erectile dysfunction.

Meet Faron Pharmaceuticals Ltd, Belvoir Lettings, Silence Therapeutics PLC, ANGLE PLC and ReNeuron Group PLC at our event, London , 23 May 2019. Register here »
View full FUM profile View Profile

Futura Medical PLC Timeline

December 17 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use